HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Infectious Disease
Safety monitoring report for COVID-19 mRNA second boosters in adults aged 50+
Safety monitoring continues for second COVID-19 booster shots in older adults
A safety monitoring report from the United States describes surveillance for adults aged 50 years and older receiving a second COVID-19 mRNA…
Health officials continue routine safety checks for second COVID-19 booster shots in adults aged 50 and older as a standard public health pr…
CDC
Apr 5, 2026
Infectious Disease
US adult vaccination coverage for influenza, COVID-19, and RSV reported in observational data
How many eligible adults are getting their flu, COVID, and RSV shots?
An observational report describes vaccination coverage among eligible US adults for influenza, COVID-19, and RSV vaccines. Specific coverage…
A new report shows how many eligible adults across the United States received flu, COVID-19, and RSV vaccines before winter.
CDC
Apr 5, 2026
Infectious Disease
U.S. surveillance shows XBB and JN.1 Omicron descendants dominated SARS-CoV-2 circulation from May 2023 to September 2024
What COVID variants are circulating in the U.S.?
A U.S. surveillance report tracking SARS-CoV-2 variant circulation from May 2023 to September 2024 found circulating lineages were primarily…
A new report shows that from May 2023 through September 2024, the COVID-19 virus spreading in the U.S. was mostly descendants of the Omicron…
CDC
Apr 5, 2026
Infectious Disease
Paxlovid prescription associated with 51% lower hospitalization risk in US adults with COVID-19
Paxlovid prescription linked to lower hospitalization risk in adults with COVID-19
An observational study of eligible US adults with COVID-19 found those prescribed Paxlovid were 51% less likely to be hospitalized. The stud…
Adults prescribed Paxlovid for COVID-19 were 51% less likely to be hospitalized compared to those who did not get the medication.
CDC
Apr 5, 2026
Infectious Disease
Observational data show lower COVID-19 rates in nursing home residents with up-to-date vaccination
Nursing home residents with current COVID-19 shots had lower weekly case rates
An observational report from U.S. nursing homes during fall/winter 2022-2023 found lower weekly rates of laboratory-confirmed COVID-19 among…
Nursing home residents who were up to date with their COVID-19 shots had lower weekly case rates between October 2022 and January 2023.
CDC
Apr 5, 2026
Infectious Disease
U.S. death rates, causes, and COVID-19-associated mortality examined in 2022 observational data
What happened to death rates in the US during the pandemic?
An observational study of the U.S. population in 2022 examined overall death rates, causes of death, and COVID-19-associated mortality. The …
A new report tracks overall death rates, causes of death, and COVID-19 deaths in the U.S. during 2022.
CDC
Apr 5, 2026
Infectious Disease
Survey reports ventilation improvement strategies in U.S. K-12 public schools for COVID-19 prevention
Survey reports ventilation improvement strategies in U.S. public schools
A survey of U.S. K-12 public schools reported on ventilation improvement strategies for COVID-19 prevention. No specific results, sample siz…
A survey reveals which ventilation strategies U.S. public schools are using to try to prevent COVID-19 spread, though it didn't test their e…
CDC
Apr 5, 2026
Infectious Disease
Observational study tracks influenza and COVID-19 vaccination coverage in US health care personnel
Study tracks flu and COVID-19 vaccination rates among U.S. health care workers
An observational study assessed influenza and COVID-19 vaccination coverage among health care personnel in the United States from October 20…
A new report tracks flu and COVID-19 vaccination rates among U.S. health care workers during the 2023-24 season, but the actual coverage num…
CDC
Apr 5, 2026
Infectious Disease
Clinical trials examine COVID-19 rebound after nirmatrelvir/ritonavir versus placebo treatment
Does the COVID-19 rebound risk change with or without Paxlovid treatment?
Randomized, double-blind trials at U.S. and international sites investigated COVID-19 rebound following nirmatrelvir/ritonavir treatment ver…
Two rigorous clinical trials are investigating whether Paxlovid treatment changes the risk of COVID-19 symptoms returning after patients sta…
CDC
Apr 5, 2026
Infectious Disease
US observational study examines dispensing trends for oral COVID-19 antivirals by zip code and social vulnerability
Are COVID-19 treatment pills reaching the communities that need them most?
An observational study in the United States examined trends in dispensing of oral antiviral drugs for COVID-19 treatment by zip code and soc…
A new report maps where COVID-19 antiviral pills are being dispensed across U.S. zip codes to check if areas with higher social vulnerabilit…
CDC
Apr 5, 2026
Infectious Disease
Observational report examines pandemic's role in adolescent sexual behaviors and healthcare access
How did the pandemic change sex and health care for U.S. high school students?
An observational report examined the role of the COVID-19 pandemic on sexual behaviors and receipt of sexual and reproductive health service…
A new report examines how the pandemic changed sexual behaviors and access to health care for U.S. high school students between 2019 and 202…
CDC
Apr 5, 2026
Infectious Disease
COVID-19 surveillance continues after U.S. Public Health Emergency declaration expires
U.S. COVID-19 surveillance continues after the Public Health Emergency ends
A surveillance report describes the state of COVID-19 monitoring in the United States following the expiration of the federal Public Health …
U.S. COVID-19 tracking shifts from emergency mode to routine long-term monitoring after the Public Health Emergency ends in May 2023.
CDC
Apr 5, 2026